HealthDay News — Adults with overweight or obesity regain much of their lost weight after cessation of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), according to a review published online ...
As electric vehicles (EVs) surge in popularity to combat climate change and reduce fossil fuel dependence, ensuring the ...
By Dr. Liji Thomas, MD New research suggests sleeping a little longer on weekends may help people who cut their sleep short ...
Background: Online gambling and sports betting have recently been legalized and expanded in North America. We aimed to evaluate long-term changes in the frequency of gambling-related helpline contacts ...
AI-enhanced optical spectroscopy revolutionizes food quality monitoring with rapid, non-destructive analysis, ensuring safety and reducing waste in production.
Background Little is known about the association between direct pollen exposure and cognitive performance. The aim of our ...
“Overall, the study reinforces that GLP-1 receptor agonists are unlikely to produce durable weight loss if used as short term interventions without longer term management plans. For many patients, ...
A year after stopping taking weight-loss drugs such as Ozempic and Wegovy, people regain—on average—60% of their lost weight. But beyond this, their regained weight plateaus, with individuals managing ...
Poultry litter (PL) has been suggested as a soil amendment to enhance soil fertility and general soil health in intensively cultivated agroecosystems. However, continuou ...
A year after stopping taking weight loss drugs such as Ozempic and Wegovy, people regain on average 60% of their lost weight – but beyond this, their weight regain plateaus, with individuals managing ...
This paper examines whether Chinese development finance is associated with faster progress toward Millennium Development Goal style targets in low- and middle-income countries. We combine AidData’s ...
A year after stopping taking weight loss drugs such as Ozempic and Wegovy, people regain, on average, 60% of their lost ...